Gentamicin Sulfate
NDC 45865-672
Product Information
Gentamicin Sulfate is a ANDA-approved product labeled by Medsource Pharmaceuticals. This product is primarily utilized in pharmaceutical processing or compounding. It is supplied as a product. This product entry covers the primary NDC 45865-672 and its associated package configuration. This profile includes active and inactive ingredient UNII references and FDA labeling data.
Primary Identification
Labeler & Regulatory Data
Marketing Timeline
Code Structure Chart
Product Details
What is NDC 45865-672?
What are the uses of this product?
Which are the associated UNII Codes?
The UNII codes for the active ingredients in this product are:
- GENTAMICIN SULFATE (UNII: 8X7386QRLV)
- GENTAMICIN (UNII: T6Z9V48IKG) (Active Moiety)
Which are the Inactive Ingredients associated UNII Codes?
The inactive ingredients are all the component of a medicinal product OTHER than the active ingredient(s). The acronym "UNII" stands for “Unique Ingredient Identifier” and is used to identify each inactive ingredient present in a product. The UNII codes for the inactive ingredients in this product are:
- BENZALKONIUM CHLORIDE (UNII: F5UM2KM3W7)
- SODIUM PHOSPHATE, DIBASIC (UNII: GR686LBA74)
- HYDROCHLORIC ACID (UNII: QTT17582CB)
- SODIUM PHOSPHATE, MONOBASIC (UNII: 3980JIH2SW)
- WATER (UNII: 059QF0KO0R)
- SODIUM CHLORIDE (UNII: 451W47IQ8X)
- SODIUM HYDROXIDE (UNII: 55X04QC32I)
What is the NDC to RxNorm Crosswalk for this product?
- RxCUI: 310467 - gentamicin sulfate 0.3 % Ophthalmic Solution
- RxCUI: 310467 - gentamicin 3 MG/ML Ophthalmic Solution
- RxCUI: 310467 - gentamicin (as gentamicin sulfate) 0.3 % Ophthalmic Solution
- RxCUI: 310467 - gentamicin sulfate 3 MG/ML Ophthalmic Solution
* Please review the full disclaimer at the bottom of this page.
Patient Education
Gentamicin Ophthalmic
Ophthalmic gentamicin is used to treat certain eye infections. Gentamicin is in a class of medications called antibiotics. It works by killing the bacteria that cause infection.
[Learn More]
* Please review the full disclaimer at the bottom of this page.